Charles River Partners with JADE Biomedical to Expand Biologics Capabilities
January 14 2021 - 8:00AM
Business Wire
Strategic partnership demonstrates Charles
River’s commitment as a global partner
Charles River Laboratories International, Inc. (NYSE: CRL) today
announced that it has entered into a strategic partnership with
JADE Biomedical (JADE), a provider of end-to-end quality management
services for the biopharmaceutical industry. The partnership will
expand Charles River’s biologics testing capabilities
geographically and help to accommodate demand for biologics
therapeutics, especially cell and gene therapies, reaffirming the
company’s commitment as a global development partner. This
strategic relationship will also enable JADE to expand their
current global Good Manufacturing Practice (GMP) product testing
operations in Shanghai into a second facility and further build
upon its current offering of comprehensive biologics quality
management and testing services.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210114005108/en/
As the biologics therapeutics industry across the globe
continues to grow at a rapid pace, so does the demand for a
reliable contract services partner. The recent growth in
commercialization efforts in the cell and gene therapy market
requires both scientific and regulatory expertise to navigate the
complex, global regulatory environment. JADE’s deep understanding
of global trends and the local environment, and its infrastructure
designed to support clients of all sizes—from local start-ups to
global organizations—makes it a highly valuable addition to Charles
River’s network. The addition of a second testing facility, which
will come online later this year, will provide additional capacity
to better support clients’ growing needs. The new facility will
offer GMP and Good Laboratory Practice (GLP) services to
clients.
Approved Quotes
- “Around the world, R&D efforts for cell and gene therapies
are in high demand. Companies are seeking global partners who
understand the complexities of this market, while also knowing how
to navigate the nuanced regulatory environment in their region.
Working with JADE, we will be able to combine our expertise to
provide localized knowledge with a deep scientific and regulatory
network, positioning both organizations as go-to partners for
clients in this competitive market.” – Birgit Girshick, Corporate
Executive Vice President, Discovery and Safety Assessment,
Biologics Testing Solutions, and Avian Vaccine Services, Charles
River
- “JADE was founded with the purpose of serving the growing needs
of the biopharmaceutical industry, not only in China, but
internationally. JADE is a contracted Biologics Quality
Organization, Bio-CQO R , where end-to-end quality and regulatory
technical services are provided as an important addition to the
biologics outsourced services industry, filling gaps in shortage of
expertise and leadership in quality and compliance. We are
extremely grateful to the conducive regulatory environment in
recent years in China, and the trust of leading, global
biopharmaceutical companies that have allowed us to form a unique
service model and brand. To continue our growth in biologics
therapeutics, especially in the gene and cell therapy space, we
needed a partner with global reach. With an industry-leading
portfolio of services and regulatory expertise, Charles River will
help us support an increasing number of clients globally and
locally.” – Claudia Lin, PhD, Founder and CEO, JADE Biomedical
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their
research and drug development efforts. Our dedicated employees are
focused on providing clients with exactly what they need to improve
and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services,
visit www.criver.com.
About JADE Biomedical (JADE)
JADE Biomedical provides expert Quality, Regulatory and
Analytical Testing Services to the Biopharmaceutical companies
worldwide. It is the world’s first registered Biologics Contract
Quality Organization, Bio-CQOR. JADE service portfolio includes
Quality Assurance, Regulatory Submission, QC Method Validation and
Testing, general CMC and Analytical Development, Facility Design
and Qualification, Cold Chain Management, etc.. JADE founder and
leaders have extensive drug regulatory experience with agencies
including NMPA, FDA, EMA, PMDA and PICS. Our growing team of
experts provide custom-made flexible yet robust Quality and CMC
systems and lead their implementation in support of clients’
clinical and commercial programs from pre-IND to post-launch. JADE
Biomedical contract testing services offer a complete range of
analytical testing services suitable for global regulatory filings
in our state of the art, global cGMP compliant labs. Our expertise
covers all therapeutics platforms including monoclonal antibodies,
Antibody-drug-conjugates, cell and gene therapies. To learn more
about JADE and for current open positions, visit
http://JADE.bio/
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210114005108/en/
Investor Contact for JADE: Claudia Lin, PhD Founder and
CEO ClaudiaLin@JADEBiomedical.com Media Contact for JADE:
James Vang Business Development Director
jamesvang@JADEbiomedical.com Investor Contact for Charles
River: Todd Spencer Corporate Vice President, Investor
Relations 781-222-6455 todd.spencer@crl.com Media Contact for
Charles River: Amy Cianciaruso Corporate Vice President, Public
Relations 781-222-6168 amy.cianciaruso@crl.com
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Apr 2023 to Apr 2024